Impact of Intravascular Brachytherapy on Patient-Reported Outcomes in Patients with Coronary Artery Disease

Sahil Rawal1, Abhishek C Sawant1, Meenakshi Sridhar1

  • 1University Medical Center, Phoenix, AZ, USA.

Insights

Intravascular brachytherapy (VBT) significantly improves patient-reported outcomes for in-stent restenosis. Quality of life, angina frequency, and activity levels showed sustained improvement post-treatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Radiation Oncology

Background:

  • Intravascular brachytherapy (VBT) is an established treatment for in-stent restenosis (ISR).
  • Patient-reported outcomes (PROs) following VBT for ISR remain incompletely understood.
  • This study investigates the impact of VBT on PROs in patients with ISR.

Purpose of the Study:

  • To evaluate the effect of VBT on patient-reported outcomes in managing in-stent restenosis.
  • To assess changes in quality of life, angina frequency, and physical activity following VBT.

Main Methods:

  • A cohort of 51 patients undergoing VBT for coronary ISR between January 2018 and September 2019 was analyzed.
  • Data collected included baseline characteristics, procedural outcomes, and adverse events.
  • Patients completed the Seattle Angina Questionnaire-7 (SAQ-7) at baseline, 1 month, and 6 months post-VBT.

Main Results:

  • The mean SAQ-7 summary score significantly improved from 53.2 to 83 at 30 days (p < .001), with sustained improvement at long-term follow-up.
  • Significant improvements were observed in Quality of Life (QoL) and angina frequency components of the SAQ-7.
  • Activity limitations also showed significant improvement, with results evident at 1 month and sustained up to a median follow-up of 17 months.

Conclusions:

  • VBT is associated with significant improvements in patient-reported outcomes for in-stent restenosis.
  • These improvements in quality of life and symptom burden are observed early and sustained over time.
  • VBT represents an effective treatment option for enhancing patient well-being in ISR management.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
134
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
231
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
234